Lv41
620 积分 2020-05-28 加入
Identification and characterization of human GDF15 knockouts
24天前
已完结
Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
2个月前
已完结
Daily ascending dosing in cynomolgus monkeys to mitigate cytokine release syndrome induced by ERY22, surrogate for T-cell redirecting bispecific antibody ERY974 for cancer immunotherapy
2个月前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
3个月前
已完结
Anti‐KIT Barzolvolimab for Chronic Spontaneous Urticaria
4个月前
已完结
Inhibition of KIT for chronic urticaria: a status update on drugs in early clinical development
4个月前
已完结
T-cell-engaging bispecific antibodies in cancer
4个月前
已完结
Prostate-specific membrane antigen expression in normal and malignant human tissues
4个月前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
4个月前
已完结
The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
4个月前
已完结
皖公网安备34019202002308
